Question 1
What is the primary focus of cancer surveillance?
Correct Answer:
To monitor cancer trends and outcomes over time
Explanation:
The primary focus of cancer surveillance is to monitor cancer trends and outcomes over time. This involves systematically collecting, analyzing, and interpreting data related to cancer incidence, prevalence, survival rates, and mortality. By tracking these trends, public health officials and researchers can identify patterns in cancer occurrences and outcomes, which helps inform healthcare policies, resource allocation, and the development of effective prevention and treatment strategies. Monitoring these trends is crucial for understanding how cancer affects different populations and how external factors such as environmental exposures, lifestyle choices, and screening practices impact cancer rates. It enables healthcare providers to address disparities, allocate resources efficiently, and ultimately improve patient care and outcomes. While identifying new cancer treatments, providing genetic counseling services, and evaluating the effectiveness of prevention methods are all important to cancer care and research, they are not the primary focus of cancer surveillance. These activities can be influenced by the findings of cancer surveillance data but do not constitute the main purpose of tracking cancer trends and outcomes.
Question 2
What is the primary purpose of the Commission on Cancer (CoC)?
Correct Answer:
To improve the quality of care for cancer patients
Explanation:
The primary purpose of the Commission on Cancer (CoC) is to improve the quality of care for cancer patients. This organization focuses on enhancing cancer care through the establishment of standards for comprehensive cancer programs, thereby ensuring that patients receive high-quality treatment and support throughout the continuum of their care. The CoC emphasizes various aspects of patient care, including timely diagnosis, effective treatment options, and supportive services, all aimed at optimizing patient outcomes and experiences. The CoC conducts accreditation processes for cancer treatment facilities, which requires adherence to specific criteria designed to foster improvements in cancer management and patient-centered care. By concentrating on quality care, the CoC ultimately works to reduce the burden of cancer on individuals and communities. The other options, while related to cancer care, do not align closely with the main mission of the CoC. Developing treatment protocols and conducting research are important aspects of cancer management but are not the primary focus of the CoC. Likewise, while financial assistance is a crucial need for many cancer patients, it does not represent the central goal of the CoC's activities.
Question 3
In the AJCC staging system, what does the "M" signify?
Correct Answer:
Metastatic involvement at a distance from the primary
Explanation:
In the AJCC (American Joint Committee on Cancer) staging system, the "M" specifically refers to "Metastatic involvement at a distance from the primary." This component of the staging system assesses whether cancer has spread beyond its original site to distant parts of the body. It is crucial for determining the overall stage of the cancer, which impacts prognosis and treatment options. The AJCC staging system is structured around four key components: T (tumor size and extent), N (the spread to regional lymph nodes), M (distant metastasis), and the overall stage grouping that incorporates these factors. Understanding the significance of the "M" aspect allows healthcare professionals to evaluate the severity of the cancer more accurately and make informed decisions regarding treatment approaches. The other choices, while related to cancer diagnosis and management, do not accurately define the "M" in the AJCC staging system. For instance, "malignancy level" refers to a broader concept of cancer aggressiveness, "molecular characteristics" pertain to genetic and phenotypic traits of tumors, and "mortality rate" assesses the frequency of death within a population due to cancer but does not relate to the staging system directly.
Question 4
In the AJCC staging system, what does the "T" represent?
Correct Answer:
Tumor size and/or extension
Explanation:
In the AJCC (American Joint Committee on Cancer) staging system, "T" specifically refers to the tumor size and/or the extent of local tumor invasion. This parameter is a critical component of staging, as it provides essential information regarding how large the tumor is and how deeply it has penetrated into surrounding tissues. Accurate assessment of the "T" classification helps determine the overall stage of the cancer, which is vital for making informed treatment decisions and predicting patient outcomes. The "T" classification is usually followed by a numerical value that indicates the extent of the disease, ranging from Tis (in situ) to T4 (larger tumors that may invade nearby structures). This clear categorization allows for consistent communication among healthcare providers and contributes to research, treatment planning, and outcome assessment. Understanding this aspect of the AJCC staging system is crucial for anyone working in oncology, as it forms the foundation for cancer management and therapeutic strategies.
Question 5
What carries de-oxygenated blood?
Correct Answer:
Pulmonary artery
Explanation:
The pulmonary artery is responsible for carrying de-oxygenated blood from the heart to the lungs. This is a crucial part of the circulatory system, specifically within the pulmonary circulation. When blood returns from the body to the right atrium of the heart, it is low in oxygen and high in carbon dioxide. The right ventricle then pumps this de-oxygenated blood into the pulmonary artery, which leads to the lungs. In the lungs, blood exchanges carbon dioxide for oxygen, which is then carried back to the heart through the pulmonary veins. This process highlights the unique role of the pulmonary artery in transporting blood that has not been oxygenated, differentiating it from other vessels in the body. Other options, such as the aorta and the pulmonary vein, are involved in transporting oxygenated blood, while the femoral artery carries oxygenated blood to the lower extremities. These distinctions underscore the specific function of the pulmonary artery in the circulatory system.
Question 1
Exam overview

About this Exam

Welcome to your essential resource for conquering the Certified Tumor Registrar (CTR) Practice Exam.

This specialized practice test is expertly designed for aspiring cancer registry professionals seeking to validate their expertise.

Achieving the CTR credential, recently rebranded as the Oncology Data Specialist-Certified (ODS-C) by the National Cancer Registrars Association (NCRA), is the premier standard for the profession.

It proves your mastery of capturing the complete history, diagnosis, treatment, and status of cancer patients in the United States.

This practice exam serves as a critical diagnostic tool, highlighting your strengths and identifying areas requiring further review before the official test day.

More details

Additional Information

What the Course Entails and Exam Details

This practice guide is structured to mirror the comprehensive nature of the actual ODS/CTR certification process.

It is not a course itself, but rather a simulation of the knowledge required for current practice.

The core areas covered include extensive knowledge of cancer registry operations and standard-setting organizations (like the ACS CoC, SEER, and CDC/NPCR).

You will be tested on complex skills including abstracting, coding (using ICD-O-3 and AJCC TNM staging), data collection, and essential data analysis.

Furthermore, it ensures competency in critical areas such as legislative and regulatory requirements, data quality assurance, and the medical science of oncology.

 

 

 What to Expect in the Final Exam

The official ODS-C certification exam is a rigorous validation of professional skill administered by the NCRA’s Council on Certification.

You should expect a timed, multiple-choice assessment, typically consisting of approximately 180 questions, 160 of which are scored and 20 are pretest items.

The time limit for this exam is generally four hours.

To pass, candidates must meet a scaled scoring requirement determined by the NCRA.

You will need to be prepared for questions that test both straightforward recall and, more crucially, the practical application of coding and abstracting rules to hypothetical patient scenarios.

 

 

How to Study and Exam Centers

Effective study for this credential requires dedication and a strategic approach.

Start by utilizing this practice exam to identify weak points; then, dedicate targeted study time to the official NCRA source materials, particularly the standard coding manuals (SEER Program Coding, AJCC Staging, and ICD-O-3).

Many successful candidates enroll in formal education programs or preparatory courses offered by recognized institutions or the NCRA itself.

When you are ready to take the official examination, it is administered by professional testing services such as Prometric.

The official exam is available at specialized physical testing centers globally and is often offered during specific testing windows throughout the year.

 

 

 Job Opportunities from the Course

Earning your ODS/CTR credential transforms your career trajectory in the vital field of cancer data management.

This certification is often the mandatory prerequisite for the following in-demand roles:

  • Certified Tumor Registrar (ODS-C)
  • Cancer Registry Manager/Director
  • Cancer Data Analyst
  • Cancer Registry Quality Assurance Coordinator
  • Oncology Data Specialist
  • Epidemiologist Assistant
  • Cancer Research Data Coordinator
Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions